Compare XYL & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XYL | VEEV |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2B | 27.4B |
| IPO Year | 2011 | 2013 |
| Metric | XYL | VEEV |
|---|---|---|
| Price | $116.58 | $171.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 25 |
| Target Price | $152.50 | ★ $280.42 |
| AVG Volume (30 Days) | ★ 2.3M | 2.2M |
| Earning Date | 04-28-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | 7.40 | ★ 25.93 |
| EPS | 0.79 | ★ 5.44 |
| Revenue | ★ $9,035,000,000.00 | $1,104,081,000.00 |
| Revenue This Year | $2.79 | $14.42 |
| Revenue Next Year | $4.49 | $12.17 |
| P/E Ratio | $145.52 | ★ $31.41 |
| Revenue Growth | 5.52 | ★ 28.05 |
| 52 Week Low | $114.15 | $148.05 |
| 52 Week High | $154.27 | $310.50 |
| Indicator | XYL | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 41.03 | 54.13 |
| Support Level | N/A | $169.92 |
| Resistance Level | $141.89 | $174.97 |
| Average True Range (ATR) | 3.03 | 5.91 |
| MACD | -0.69 | 1.85 |
| Stochastic Oscillator | 20.22 | 84.26 |
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.